Please login to the form below

Not currently logged in
Email:
Password:

Acetylon

This page shows the latest Acetylon news and features for those working in and with pharma, biotech and healthcare.

Celgene pays $300m upfront for immunology start-up Delinia

Celgene pays $300m upfront for immunology start-up Delinia

and autoimmune disease firm Acetylon and a $295m discovery alliance with Evotec for stem cell therapies.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals during July 2013 Pharma deals during July 2013

    Following its $15m investment in Acetylon Pharmaceuticals last year, Celgene has moved another step closer to acquiring the company. ... In addition, Acetylon shareholders could receive future milestone payments of up to $1.1bn based on regulatory ($250m)

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    110. Acetylon Pharmaceuticals / Celgene. Collaboration and option to acquire. HDAC inhibitors inc ACY-1215 for multiple myeloma (p1b).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Targovax strengthens board of directors Targovax strengthens board of directors

    Catherine Wheeler joins from Acetylon Pharmaceutical. Clinical stage company Targovax has added to its board of directors with the appointment of Catherine Wheeler. ... Most recently, Wheeler served Acetylon Pharmaceutical as chief medical officer and

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics